XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jul. 02, 2022
Jul. 03, 2021
Operating Activities    
Net Income Attributable to Kadant $ 67,362 $ 39,425
Net income attributable to noncontrolling interest 488 398
Net Income 67,850 39,823
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 17,931 15,402
Stock-based compensation expense 4,536 4,026
Provision for losses (benefit) on accounts receivable 433 (241)
Gain on the sale of assets (Note 2) (20,190) 0
Noncash impairment costs (Note 2) 182 0
Other items, net 6,964 1,752
Changes in assets and liabilities, net of effects of acquisitions:    
Accounts receivable (12,336) (15,321)
Unbilled revenue (3,694) 1,005
Inventories (26,816) (7,312)
Other assets 686 (3,209)
Accounts payable (287) 12,904
Customer deposits 9,329 11,112
Other liabilities (2,023) 3,537
Net cash provided by operating activities 42,565 63,478
Investing Activities    
Acquisitions, net of cash acquired (62) (159)
Purchases of property, plant, and equipment (9,815) (4,318)
Proceeds from sale of property, plant, and equipment 1,942 71
Other 41 537
Net cash used in investing activities (7,894) (3,869)
Financing Activities    
Repayment of short- and long-term obligations (51,379) (47,138)
Proceeds from issuance of short- and long-term obligations 16,516 88,888
Tax withholding payments related to stock-based compensation (4,589) (3,388)
Dividends paid (5,936) (5,664)
Net cash (used in) provided by financing activities (45,388) 32,698
Exchange Rate Effect on Cash, Cash Equivalents, and Restricted Cash (5,418) (803)
(Decrease) Increase in Cash, Cash Equivalents, and Restricted Cash (16,135) 91,504
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period 94,161 66,640
Cash, Cash Equivalents, and Restricted Cash at End of Period $ 78,026 $ 158,144